Friday, September 25, 2026 Never miss a recall or a rule change Get the free brief →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
Devices & TechECHOLASER X4 Clears FDA 510(k) for General Surgerylast weekBusiness & M&AAbbVie Files Material Event—Allē Rebate Terms Shifting7 weeks agoDevices & TechVIOL Scarlet Pro Wins FDA 510(k) Clearance2 weeks agoComplianceEvolus Rewards Program Terms Changed—Review Now7 weeks agoDevices & TechHebei Zollvan Diode Laser Clears FDA 510(k)2 weeks agoBusiness & M&ARejuran Maker PharmaResearch Acquires Cosmetic Group5 weeks agoBusiness & M&AAbbVie Files Material Event: Botox/Juvéderm Pricing Shift3 weeks agoBusiness & M&AAbbVie Files Material Event on Allergan Aesthetics5 weeks agoSearch DemandWho Can Inject Botox and Filler in Florida: Scope of Practice and Licensure Requirements4 weeks agoMarketGLP-1 Pill Era Is Forcing Beauty Market Shift5 weeks agoSearch DemandMedical Spa Revenue Calculator: Model Your Practice Economics4 weeks agoSearch DemandGood Faith Exam for Med Spas: State Requirements, Scope, and Compliance4 weeks ago
Devices & Tech

The Consumables Trap: Why 'Cheap' Energy Devices With Per-Tip Costs Beat You on Margin

A low sticker price with a disposable tip is the oldest play in capital equipment. The acquisition cost is the bait; the consumable is where the manufacturer actually makes its money, out of yours.

A medical professional performs a laser treatment on a patient's arm, focusing on healthcare and wellness.
Photo: Orhun Rüzgar ÖZ / Pexels

Get the free Inside MedSpa brief by email

The free Inside MedSpa brief · no card · unsubscribe anytime. Privacy.

The cheapest energy device on the floor at the conference is almost never the cheapest device to own, and experienced owners know to get suspicious precisely when the acquisition price feels like a deal. There's a reason the razor is affordable and the blades are not, and the aesthetic-device industry learned that lesson a long time ago. The platform is the razor. The disposable tip is the blade. And the low sticker price is bait for a multi-year consumable subscription most buyers don't recognize as a subscription until they're a year deep.

This isn't a reason to avoid consumable-based devices. Plenty of them are excellent investments. It's a reason to evaluate them on the only number that matters: fully loaded cost per treatment, instead of the headline that was engineered to disarm you.

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

The free Inside MedSpa brief · no card · unsubscribe anytime. Privacy.

The razor is cheap because the blades aren't. In aesthetic devices, the platform is the razor and the tip is the blade, and you signed a multi-year subscription you didn't realize was a subscription.

Where the manufacturer actually makes money

For a consumable-driven platform, the purchase price is a customer-acquisition cost for the manufacturer. Their margin lives in the recurring tip, cartridge, or per-cycle disposable that you buy for the life of the device. Over a few years of utilization, that consumable stream frequently exceeds what you paid for the machine. A low acquisition price isn't generosity; it's an investment in locking in your disposable purchases, which is where the real economics are.

That's a fine business model, for them. Your job is to make sure it's also a good one for you, and the only way to know is to put the disposable where it belongs: at the center of the analysis, not in a footnote.

The mental-model error that kills margin

The expensive mistake isn't buying a consumable device. It's buying one and then pricing your treatments as if the tip were free, anchoring your market price on what tip-free competitors charge, or on a gut sense of "what the treatment is worth," while a $150–$400 disposable quietly comes off the top of every single session.

The result is the most demoralizing kind of unprofitable: a busy device. The room is booked, the platform is utilized, the patients are happy, and the device still barely clears its cost because nobody priced the blade into the razor. Utilization didn't save it; utilization just ran the bad per-treatment math more times.

Model it honestly before you sign

The fair evaluation is simple to state and the manufacturer would prefer you skip it:

  • Get the real disposable cost in writing: per treatment, including any minimum purchase commitments, before any conversation about the platform price.
  • Build a fully loaded cost per treatment: disposable, plus the prorated service contract, plus provider time, plus room time.
  • Compare that to your realistic market price and volume. If the loaded cost crowds your price, the device only works at a throughput or a price point you may not have.

Run that, and consumable devices sort themselves into two piles: the ones where throughput and pricing genuinely support the disposable and the device prints money, and the ones where the tip was always going to eat you. Both look identical on the sticker.

What to do

  • Never evaluate a consumable device on acquisition price. Treat the sticker as the least important number and the disposable as the most important.
  • Demand per-treatment consumable cost and any minimum commitments in writing, and assume the rep's framing understates real-world usage.
  • Price every treatment off loaded cost per session, with the disposable in it, not off what a tip-free competitor charges.
  • Stress-test at your real volume. If the device only works at a utilization you can't hit, it doesn't work.

The consumables trap isn't a scam. It's a business model, and a legitimate one. The trap is letting the low sticker price do its job, which is to stop you from doing the math. Do the math, price the blade into the razor, and a consumable device can be a great line. Skip it, and you'll spend years busy and broke on a machine that technically paid for itself while quietly never making you a dime.

Frequently asked questions

Why are some aesthetic devices priced low up front?

Because the manufacturer's margin is in the recurring consumable (the per-treatment tip, cartridge, or cycle), not the platform. A low acquisition cost lowers your resistance to buying; the disposable then generates ongoing revenue for the manufacturer over the life of the device, often exceeding the original purchase price.

How do I evaluate a consumable-based device fairly?

Model the fully loaded cost per treatment including the disposable, then compare it to your realistic price and volume. A consumable device can be excellent if throughput and pricing support it. The error is evaluating it on the sticker price as if the tip were free.

Are tip-free devices always better?

No. Tip-free platforms have their own costs, often a higher acquisition price and service burden. The point isn't to avoid consumables; it's to price them in honestly and choose based on total cost per treatment at your real volume, not on the headline.

What's the worst-case consumable scenario?

A device bought on a low sticker, priced into the market on a tip-free mental model, where the per-treatment disposable quietly consumes most of the margin. The practice is busy, the device is utilized, and it still barely makes money. Volume amplifies a bad per-treatment number rather than fixing it.

Business information, not medical or legal advice. Verify product status at FDA.gov.

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

The free Inside MedSpa brief · no card · unsubscribe anytime. Privacy.

Share

https://insidemedspa.com/article/device-consumables-trap-per-tip-margin/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Inside MedSpa · Free brief

    By the time it's news, it's too late.

    FDA decisions, recalls and the rules you operate under, drafted from the source documents and sent free by email.

    Get the free brief The free Inside MedSpa brief · no card · unsubscribe anytime.
    FDA, recalls and rule changes for practice owners Get the free brief →